MDCO insider buy notable for two reasons: i) the amount ($10.1M); and ii) the buyer, Fredric Eshelman, who founded two biotech companies that were sold at nice premiums (PPDI and FURX).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”